期刊文献+

虫草素调节MAPK/AP-1信号通路对慢性阻塞性肺疾病大鼠肺组织损伤的影响 被引量:3

Effects of cordycepin on lung tissue injury in rats with chronic obstructive pulmonary disease by regulating MAPK/AP-1 signal pathway
下载PDF
导出
摘要 目的 基于丝裂原活化蛋白激酶(MAPK)/激活蛋白-1(AP-1)信号通路探讨虫草素(Cor)对慢性阻塞性肺疾病大鼠肺组织损伤的改善作用。方法 利用烟熏联合脂多糖滴入气管的方法建立慢性阻塞性肺疾病大鼠模型,将造模大鼠随机分为模型组(COPD)、虫草素低、中、高剂量组(Cor-L、M、H,10、20、50 mg/kg)、阳性对照组(NAC,0.5 g/kg),另设置正常培养的大鼠为对照组(NC)。使用肺功能仪检测大鼠肺功能指标呼气峰流速(PEF)、用力肺活量(FVC);HE染色观察大鼠肺组织病理学变化;对肺泡灌洗液白细胞进行计数分离;ELISA法检测肺泡灌洗液中TNF-α、IL-6和LTB4水平;微量法试剂盒检测肺组织中MDA、SOD、GSH-Px水平;Western Blot检测MAPK/AP-1信号通路蛋白表达。结果 与NC组比较,COPD组大鼠肺组织出现肺泡肿大,炎性细胞浸润等病理学变化,肺功能(PEF、FVC)、巨噬细胞比率、淋巴细胞比率、SOD、GSH-Px活性显著下降,白细胞数目、中性粒细胞比率、TNF-α、IL-6和LTB4水平、MDA含量、p-ERK/ERK、p-JNK/JNK、p-p38/p38、C-jun、C-fos蛋白表达显著上升(P<0.05);与COPD组比较,Cor各剂量组、NAC组大鼠肺组织病理学变化明显好转,肺功能(PEF、FVC)、巨噬细胞比率、淋巴细胞比率、SOD、GSH-Px活性显著上升,白细胞数目、中性粒细胞比率、TNF-α、IL-6和LTB4水平、MDA含量、p-ERK/ERK、p-JNK/JNK、p-p38/p38、C-jun、C-fos蛋白表达显著下降(P<0.05);NAC组与Cor-H组上述指标无显著差异(P>0.05)。结论 虫草素可以抑制MAPK/AP-1信号通路,减轻炎症反应和氧化应激,改善慢性阻塞性肺疾病大鼠肺组织病理损伤。 Objective To investigate the improvement of cordycepin(Cor)on lung tissue injury in rats with chronic obstructive pulmonary disease(COPD)based on the mitogen-activated protein kinase(MAPK)/activator protein-1(AP-1)signal pathway.Methods A rat model of chronic obstructive pulmonary disease was established by smoking combined with lipopolysaccharide dripping into the trachea.The model rats were randomly grouped into a model group(COPD),low,medium,and high dose cordycepin groups(Cor-L,M,H,10,20,50 mg/kg),positive control group(NAC,0.5 g/kg),and normal cultured rats were set as the control group(NC).The lung function indexes peak expiratory flow(PEF),forced vital capacity(FVC)of rats were measured by lung function instrument;HE staining was applied to observe the pathological changes of lung tissue in rats;the white blood cells of alveolar lavage fluid were counted and separated;the levels of TNF-α,IL-6,and LTB4 in alveolar lavage fluid were detected by ELISA;the levels of MDA,SOD,and GSH-Px in lung tissue were detected with the micro-method kit;and Western blot was applied to detect the expression of MAPK/AP-1 signal pathway protein.Results Compared with the NC group,the lung tissue of COPD group showed pathological changes such as alveolar swelling and inflammatory cell infiltration,the lung function(PEF,FVC),macrophage ratio,lymphocyte ratio,SOD and GSH-Px activities were lower,the number of white blood cells,neutrophil ratio,TNF-α,IL-6 and LTB4 levels,MDA content,p-ERK/ERK,p-JNK/JNK,p-p38/p38,C-jun,C-fos protein expression were higher(P<0.05);compared with COPD group, the pathological changes of lung tissue of rats in Cor groups and NAC group were improved, the lung function (PEF, FVC), macrophage ratio, lymphocyte ratio, SOD and GSH-Px activities were higher, the number of white blood cells, neutrophil ratio, TNF-α, IL-6 and LTB4 levels, MDA content, p-ERK/ERK, p-JNK/JNK, p-p38/p38, C-jun, C-fos protein expression were lower ( P <0.05);there was no obvious difference in the above indexes between NAC group and Cor-H group ( P >0.05). Conclusion Cordycepin can inhibit MAPK/AP-1 signal pathway, reduce inflammatory reaction and oxidative stress, and improve lung tissue pathological damage in rats with chronic obstructive pulmonary disease.
作者 陈才伟 陈家亮 李华娟 方芳 文方玲 CHEN Caiwei;CHEN Jialiang;LI Huajuan;FANG Fang;WEN Fangling(Department of Respiratory Medicine,the First Affiliated Hospital of Hainan Medical College,Haikou,Hainan 570102,China)
出处 《临床肺科杂志》 2023年第11期1656-1661,共6页 Journal of Clinical Pulmonary Medicine
基金 海南省卫生计生行业科研项目(No.19A200115)。
关键词 虫草素 慢性阻塞性肺疾病 肺组织损伤 MAPK/AP-1信号通路 Cordycepin Chronic obstructive pulmonary disease Lung tissue injury MAPK/AP-1 signal pathway
  • 相关文献

参考文献9

二级参考文献49

  • 1王秋月,许惟元,程青,康健,于润江.慢性阻塞性肺疾病患者生活质量影响因素分析(英文)[J].中国现代医学杂志,2005,15(4):493-496. 被引量:14
  • 2陈自力,方宗君.慢性阻塞性肺疾病急性加重频率与患者生活质量的关系[J].中国临床康复,2005,9(27):10-12. 被引量:15
  • 3GLOD Executive committee.Global initiative for chronic obstructive lung diseasepocket guide to COPD diagnosis, management and prevention 2011.
  • 4RabeKF, Hurd S,Anzueto A,et al.Global strategy for the diagnosis ,management, and prevention of chronic obstructive pulmonary disease: Gold executive summary [J].Am J Respir Crit Care Med,2007,176(6):532-555.
  • 5M K Daga, Rashmi chhabra,Bhavneesh sharma and T Mishra.Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease[J]. Biosci.2003,28:1-2.
  • 6Sadowska AM,Manuel-Y-Keenoy B,De Backer WA.Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD:Discordant in vitro and in vivo dose-effects:Areview[J].Pulm Pharmacol Ther,2007,20:9-22.
  • 7Zuin R,Palamidese A,Negrin R,et al.High dose N-Acetylcisteine in Patients with Exacerbations of Chronic Obstructive Pulmonary Diseases[J].Clin Drug Invest,2005,25(6);401-408.
  • 8Engstrom CP,Persson LO,Larsson S,et al.Health-reIated quality of life in COPD:why both disease-specific and generic measures should be used[J].Eur Respir J,2001,18:69-76.
  • 9李宇航,钟相根,贾旭,孙燕,郑丰杰,王蔚,周晓卫,祝小惠,田彦,刘晓辉.“通利大肠”对慢性阻塞性肺疾病模型大鼠氧化应激的影响[J].中华中医药杂志,2010,25(8):1196-1198. 被引量:17
  • 10马春兰,陈红,梁斌苗,冯玉麟.N-乙酰半胱氨酸对慢性阻塞性肺疾病稳定期作用的Meta分析[J].中国循证医学杂志,2011,11(10):1156-1160. 被引量:22

共引文献74

同被引文献38

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部